Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture plc (ACN) director reports small equity award linked to dividend. On 11/14/2025, a director acquired 5 Class A ordinary shares at a price of $0, increasing their beneficial ownership to 624 shares held directly. The filing explains that this was a grant of restricted share units made under anti-dilution provisions of previously granted RSU awards, intended to reflect Accenture’s payment of a cash dividend. This is a routine adjustment that keeps the director’s prior equity awards economically consistent after the dividend payment.
Accenture plc (ACN) reported a Form 4 for its CEO-The Americas, John F. Walsh, covering equity award adjustments tied to a recent cash dividend. On 11/14/2025, he acquired 93 Class A ordinary shares at $0 per share through a grant of restricted share units (RSUs) made under the anti-dilution provisions of previously granted RSU awards. On the same date, 41 Class A ordinary shares were disposed of at $246.62 per share, reported with transaction code “F,” which typically reflects shares withheld to cover tax obligations. Following these transactions, he beneficially owned 22,422 Class A ordinary shares, held directly.
Accenture plc (ACN) Chair and CEO Julie Spellman Sweet, who also serves as a director, reported changes in her Accenture share holdings. On 11/14/2025, she acquired 333 Class A ordinary shares at $0 per share, increasing her position through a grant of restricted share units (RSUs) made under anti-dilution provisions tied to Accenture’s payment of a cash dividend. On the same date, she had a disposition coded “F” of 148 Class A ordinary shares at $246.62 per share. After these transactions, she beneficially owned 8,941 Class A ordinary shares in direct ownership.
Accenture plc officer Katherine Lee Clifford reported receiving a grant of 32 Class A ordinary shares in the form of restricted share units. The grant occurred on 11/14/2025 at a price of $0 per share, reflecting anti-dilution adjustments to previously granted RSU awards following Accenture plc's payment of a cash dividend.
After this transaction, Clifford beneficially owns 4,919 Class A ordinary shares directly and 27 shares indirectly through an immediate family member. The filing is made on behalf of Clifford by an attorney-in-fact and reflects routine equity compensation adjustments tied to dividend payments rather than an open-market purchase or sale.
Accenture plc officer Ryoji Sekido, Co-CEO Asia Pacific, reported a new equity award in the company’s Class A ordinary shares. On 11/14/2025, he acquired 26 shares at a price of $0, recorded as a grant of restricted share units under existing awards. The filing explains that these RSUs were issued pursuant to anti-dilution provisions to reflect Accenture’s payment of a cash dividend, meaning the award adjusts prior grants so their value is maintained after the dividend. Following this transaction, Sekido beneficially owns 1,416 Accenture Class A ordinary shares in direct form.
Accenture plc (ACN) reported an insider equity transaction by its Chief Executive Officer-EMEA, Mauro Macchi. On 11/14/2025, he received a grant of 26 Class A ordinary shares in the form of restricted share units, issued under anti-dilution provisions to reflect Accenture’s cash dividend. On the same date, 12 Class A ordinary shares were disposed of at $246.62 per share under code “F,” indicating shares withheld, typically for tax obligations. Following these transactions, he directly beneficially owns 4,415 Class A ordinary shares.
Accenture plc director reports small anti-dilution RSU grant
A director of Accenture plc (ACN) reported receiving 5 Class A ordinary shares on 11/14/2025 through a grant of restricted share units. The filing explains that these RSUs were granted under the anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend, so the director did not pay any purchase price, which is shown as $0 per share. Following this adjustment, the director beneficially owns 3,708 Class A ordinary shares directly.
Accenture plc (ACN) reported that director Arun Sarin received a grant of 5 Class A ordinary shares in the form of restricted share units. The grant was made pursuant to anti-dilution provisions in previously granted RSU awards to reflect Accenture’s payment of a cash dividend, and carried a stated price of $0. Following this adjustment, Sarin beneficially owns 8,478 Class A ordinary shares in the company, held directly. This filing reflects a routine, small equity adjustment rather than a market purchase or sale.
Accenture plc (ACN) reported an insider share purchase by its Chief Operating Officer, Catherine Kiernan Hogan. On 11/05/2025, she acquired 87 Class A ordinary shares at $245.875 per share, recorded as an acquisition under the company’s Voluntary Equity Investment Program.
Following the transaction, she beneficially owns 10,121 shares direct and 2,048 shares indirect through a family trust. This is a routine Form 4 disclosure of insider ownership activity.
Accenture (ACN) Chair and CEO Julie Sweet reported insider trades on 11/05/2025 under a Rule 10b5-1 Trading Plan. She sold a total of 5,917 Class A shares in multiple transactions at weighted average prices of $243.38, $246.419, $247.2254, and $248.825, and acquired 157 shares at $245.875 through the Accenture Voluntary Equity Investment Program. Following these transactions, she beneficially owned 8,756 Class A shares.